Carlsmed (CARL): Officer filed to sell ~$3.8K
Bertolini Jeffrey, Officer at Carlsmed, filed to sell ~$3.8K of Carlsmed shares.
- ~$3.8K
- planned to sell · 243 shares, around Oct 30, 2026
- Planned for
- Oct 30, 2026
- Notice filed
- Oct 30, 2026
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jul 24, 2025Insider10% owner purchased ~$3M of CARL shares in the open market
- Sep 4, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 4, 2026, the Board of Directors of Carlsmed, Inc. (the “Company”) appointed Jeffrey Bertolini as Chief Operating Officer of the Company, effective September 8, 2026.”
- Sep 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On September 28, 2026, Carlsmed, Inc. (the “Company”) announced that Leo Greenstein has departed his role as the Company’s Chief Financial Officer, effective September 25, 2026 (the “Separation Date”).”
- Sep 24, 2026FDAFDA device clearance: corra® cervical plating system
- Sep 30, 2026InsiderOfficer sold ~$3.4K of CARL shares in the open market
- Oct 5, 2026InsiderOfficer sold ~$11K of CARL shares in the open market
- Oct 30, 2026InsiderOfficer sold ~$3.8K of CARL shares in the open market
What came next
How to read SEC Form 144
Form 144 is a notice that a company insider plans to sell shares. It is filed when the sell order is placed, so it announces a planned sale and does not prove that the sale took place.
Full guide: What is an SEC Form 144?
What else is on file for Carlsmed
For Carlsmed, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CARL page.
How this filing works
Explore the data
Common questions
Which Carlsmed (CARL) insider traded, and how much?
Bertolini Jeffrey, Officer at Carlsmed, filed to sell ~$3.8K of Carlsmed shares. 243 shares, Form 144 notice of a planned sale.
When did it happen, and when was it made public?
Planned for: Oct 30, 2026. Notice filed: Oct 30, 2026.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 144, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Carlsmed recently?
For Carlsmed, OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the CARL page.
Does this mean CARL stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Carlsmed
- SEC Form 4Nov 4, 2026
- SEC Form 144Nov 3, 2026
- SEC Form 4Nov 2, 2026
- SEC Form 144Oct 14, 2026
- SEC Form 4Oct 7, 2026
- SEC Form 144Oct 5, 2026
Everything OQRO holds on this company is on its CARL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
